News & Analysis on Clinical Trial Services & Contract Research And Development
Contract development and manufacturing company Patheon received an unsolicited takeover bid from private equity firm JLL Partners ahead of reporting a return to profit in its fiscal fourth quarter results.
TransPharma Medical has received the European CE mark for its transdermal drug delivery device ViaDerm, which creates pores to allow a therapeutic through the skin.
The global financial difficulties are starting to hit home in the outsourcing sector, with supply chain services company Syscan filing for bankruptcy after being unable to secure a loan.
The FDA has issued draft guidance on how manufacturers should evaluate the safety of products that contain genotoxic and carcinogenic impurities.
PPD’s admission to the Nasdaq’s 100 index, which covers the elite group of non-financial firms to be listed on the Nasdaq Stock Exchange, is a definitive moment for the CRO, according to CEO Fred Eshelman.
German inhaled drug specialist Aeropharm will use Prosonix’ sonocrystallisation technology to develop generics in its candidate pipeline.
Australian drug development firm Cancer Therapeutics (CTx) has selected IDBS’ E-workbook and ActivityBase platforms to manage its global drug development programmes.